HYPE price continued to lose ground despite recent encouraging development including burn proposals, imminent ETF launch, and ...

Sven Blume’s Lewerentz Divine Darkness is an essay, documented in film—possibly the only medium that can communicate time and ...

The intersection of technical debt and political sparring has manifested as a visceral survival crisis for the millions of Ghanaians dependent on the "golden pod." This systemic failure has triggered ...

Its trailer got a prime Game Awards slot, but the online shooter has failed to find a large audience.

Silver triggered a bullish reversal and reclaimed its 50-day average, hinting at recovery, but resistance ahead and recent ...

In recent years, a significant shift in U.S. immigration processes has elevated investment-based immigration from a minor strategy to a core tool in the playbook of Indian individuals and families ...

Colorado Buffaloes transfer wide receiver Ernest Campbell made a historic first impression on the Buffaloes' track and field ...

The Cardano blockchain's native token, ADA, has achieved a significant milestone in its journey toward mainstream financial ...

Thai voters headed to the polls on Sunday in what is seen as a three-cornered contest, with most pre-poll surveys signaling a ...

GeoVax Labs, Inc. (Nasdaq: GOVX) (the "Company"), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it has ...

AST SpaceMobile, Inc. ("AST SpaceMobile") (NASDAQ: ASTS), the company building the first and only space-based cellular ...

Investing.com -- The U.S. Food and Drug Administration (FDA) has approved Merck ’s pembrolizumab (Keytruda) and pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for treating certain ...